Physician profile
Holly Bennett
NPI 1861784423
$734.98
in general payments reported to CMS, 2019-2025
15 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $306 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $133.47 | 2024-2025 | Repatha, Otezla, Krystexxa |
| Coloplast Corp | $130.56 | 2024 | |
| Medtronic, INC. | $109.05 | 2023 | Corevalve Evolut R |
| Exact Sciences Corporation | $57.58 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $47.14 | 2024-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $46.83 | 2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Hologic Sales and Service, LLC | $34.30 | 2025 | Novasure |
| Astrazeneca Pharmaceuticals LP | $31.85 | 2024-2025 | Farxiga, Airsupra |
| Pfizer INC. | $29.22 | 2024-2025 | |
| Heartflow, INC. | $23.46 | 2023 | Ffrct |
| Merck Sharp & Dohme LLC | $19.90 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Vertex Pharmaceuticals Incorporated | $18.63 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.40 | 2025 | |
| Lilly USA, LLC | $17.42 | 2024 | Jardiance |
| Lundbeck LLC | $17.17 | 2025 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.